Glucagon-Like Peptide-1 Receptor Agonists Cardio-protective effects: an umbrella review.

CONCLUSION: The RCT-s for GLP-1 RA should characterize cardiovascular risk in subjects with diabetes such that disparities between established cardiovascular risk (high, moderate and low), or medical history of cardiovascular disease been accounted for in subgroup analysis.
PMID: 32442089 [PubMed - as supplied by publisher]

Source: Current Diabetes Reviews - May 21, 2020 Category: Endocrinology Authors: Elnour AA, Al Hajri N, El Khidir IY, Al Amoodi A, Ahmed SA, Sadeq A Tags: Curr Diabetes Rev Source Type: research